ARCHIVES

Clearinghouse Exec. Secty, Says It Has Failed in Its Objectives, Recommends It Be Dropped

This article is from The Cancer Letter archive.

Vol. 04 No. 02 | January 13, 1978

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

Final Issue of ‘87

December 11, 1987

Hopkins to Commit Own Money for Junior Faculty Research

May 2, 1986

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

July 27, 2007

President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel

June 1, 2001

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980